MED31 anticorps (N-Term)
Aperçu rapide pour MED31 anticorps (N-Term) (ABIN632918)
Antigène
Voir toutes MED31 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- MED31 antibody was raised against the N terminal of MED31
-
Purification
- Affinity purified
-
Immunogène
- MED31 antibody was raised using the N terminal of MED31 corresponding to a region with amino acids MAAAVAMETDDAGNRLRFQLELEFVQCLANPNYLNFLAQRGYFKDKAFVN
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
MED31 Blocking Peptide, (ABIN5614719), is also available for use as a blocking control in assays to test for specificity of this MED31 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MED31 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- MED31 (Mediator Complex Subunit 31 (MED31))
-
Autre désignation
- MED31
-
Sujet
- MED31 is the component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes.
-
Poids moléculaire
- 16 kDa (MW of target protein)
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Antigène
-